307 related articles for article (PubMed ID: 18929073)
1. Gender differences in pharmacological response.
Anderson GD
Int Rev Neurobiol; 2008; 83():1-10. PubMed ID: 18929073
[TBL] [Abstract][Full Text] [Related]
2. Do women have more adverse drug reactions?
Rademaker M
Am J Clin Dermatol; 2001; 2(6):349-51. PubMed ID: 11770389
[TBL] [Abstract][Full Text] [Related]
3. Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach.
Anderson GD
Clin Pharmacokinet; 2005; 44(10):989-1008. PubMed ID: 16176115
[TBL] [Abstract][Full Text] [Related]
4. Drug-induced long QT syndrome in women: review of current evidence and remaining gaps.
Hreiche R; Morissette P; Turgeon J
Gend Med; 2008 Jun; 5(2):124-35. PubMed ID: 18573480
[TBL] [Abstract][Full Text] [Related]
5. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
6. Gender-specific implications for pharmacology in childbearing age and in postmenopausal women.
Bartkowiak-Wieczorek J; Wolski H; Bogacz A; Kujawski R; Ożarowski M; Majchrzycki M; Seremak-Mrozikiewicz A
Ginekol Pol; 2015 Feb; 86(2):143-9. PubMed ID: 25807840
[TBL] [Abstract][Full Text] [Related]
7. The effects of gender, age, ethnicity, and liver cirrhosis on cytochrome P450 enzyme activity in human liver microsomes and inducibility in cultured human hepatocytes.
Parkinson A; Mudra DR; Johnson C; Dwyer A; Carroll KM
Toxicol Appl Pharmacol; 2004 Sep; 199(3):193-209. PubMed ID: 15364537
[TBL] [Abstract][Full Text] [Related]
8. Second-generation antipsychotics: is there evidence for sex differences in pharmacokinetic and adverse effect profiles?
Aichhorn W; Whitworth AB; Weiss EM; Marksteiner J
Drug Saf; 2006; 29(7):587-98. PubMed ID: 16808551
[TBL] [Abstract][Full Text] [Related]
9. Gender differences in human pharmacokinetics and pharmacodynamics.
Fletcher CV; Acosta EP; Strykowski JM
J Adolesc Health; 1994 Dec; 15(8):619-29. PubMed ID: 7696281
[TBL] [Abstract][Full Text] [Related]
10. Sex-related differences in pharmacokinetics and pharmacodynamics of anti-hypertensive drugs.
Ueno K; Sato H
Hypertens Res; 2012 Mar; 35(3):245-50. PubMed ID: 22089536
[TBL] [Abstract][Full Text] [Related]
11. CYP2B6*6, CYP2B6*18, Body weight and sex are predictors of efavirenz pharmacokinetics and treatment response: population pharmacokinetic modeling in an HIV/AIDS and TB cohort in Zimbabwe.
Dhoro M; Zvada S; Ngara B; Nhachi C; Kadzirange G; Chonzi P; Masimirembwa C
BMC Pharmacol Toxicol; 2015 Mar; 16():4. PubMed ID: 25889207
[TBL] [Abstract][Full Text] [Related]
12. Cytochrome P450 sex differences in minipigs and conventional pigs.
Skaanild MT; Friis C
Pharmacol Toxicol; 1999 Oct; 85(4):174-80. PubMed ID: 10563516
[TBL] [Abstract][Full Text] [Related]
13. Sex differences in pharmacokinetics predict adverse drug reactions in women.
Zucker I; Prendergast BJ
Biol Sex Differ; 2020 Jun; 11(1):32. PubMed ID: 32503637
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous quantification of the abundance of several cytochrome P450 and uridine 5'-diphospho-glucuronosyltransferase enzymes in human liver microsomes using multiplexed targeted proteomics.
Achour B; Russell MR; Barber J; Rostami-Hodjegan A
Drug Metab Dispos; 2014 Apr; 42(4):500-10. PubMed ID: 24408517
[TBL] [Abstract][Full Text] [Related]
15. How important are gender differences in pharmacokinetics?
Meibohm B; Beierle I; Derendorf H
Clin Pharmacokinet; 2002; 41(5):329-42. PubMed ID: 12036391
[TBL] [Abstract][Full Text] [Related]
16. [Sex differences in pharmacology].
Brøsen K
Ugeskr Laeger; 2007 Jun; 169(25):2408-11. PubMed ID: 17594829
[TBL] [Abstract][Full Text] [Related]
17. Gender differences in pharmacokinetics and pharmacodynamics.
Beierle I; Meibohm B; Derendorf H
Int J Clin Pharmacol Ther; 1999 Nov; 37(11):529-47. PubMed ID: 10584975
[TBL] [Abstract][Full Text] [Related]
18. Gender-based differences in pharmacokinetics in laboratory animal models.
Czerniak R
Int J Toxicol; 2001; 20(3):161-3. PubMed ID: 11488558
[TBL] [Abstract][Full Text] [Related]
19. In vitro inhibitory mechanisms and molecular docking of 1'-S-1'-acetoxychavicol acetate on human cytochrome P450 enzymes.
Haque AKMM; Leong KH; Lo YL; Awang K; Nagoor NH
Phytomedicine; 2017 Jul; 31():1-9. PubMed ID: 28606510
[TBL] [Abstract][Full Text] [Related]
20. Sex and racial differences in pharmacological response: where is the evidence? Pharmacogenetics, pharmacokinetics, and pharmacodynamics.
Anderson GD
J Womens Health (Larchmt); 2005; 14(1):19-29. PubMed ID: 15692274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
